Basel Medical Group (BMGL) Stock Price, News & Analysis

Company Overview

Basel Medical Group Ltd. is an investment holding company, which engages in providing orthopedic surgeries, medical care, and diagnosis services. Its services include orthopedic surgeries, medical care, rehabilitative therapy, physiotherapy, non-surgical treatments, medical diagnosis, magnetic resonance imaging, general surgery, x-ray, lump removal, sports medicine, and total hip replacement. The company was founded by Man Hing Yip on August 10, 2023 and is headquartered in Singapore.

Key Stats

• Today's Range: $0.56 to $0.61
• 50-Day Range: $0.55 to $0.74
• 52-Week Range: $0.49 to $9.40
• Volume: 22,505 shs
• Average Volume: 17,555 shs
• Market Capitalization: $11.41 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Sell

Basel Medical Group Stock Analysis - MarketRank™

Basel Medical Group scored higher than 4% of companies evaluated by MarketBeat, and ranked 841st out of 856 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 0.7 / 5
• Analyst Rating: Sell

Consensus Rating

Basel Medical Group has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

Amount of Analyst Coverage

Basel Medical Group has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Book Value per Share Ratio

Basel Medical Group has a P/B Ratio of 3.04. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.59% of the float of Basel Medical Group has been sold short.

Short Interest Ratio / Days to Cover

Basel Medical Group has a short interest ratio ("days to cover") of 9.13.

Change versus previous month

Short interest in Basel Medical Group has recently decreased by 0.97%, indicating that investor sentiment is improving.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Basel Medical Group does not currently pay a dividend.

Dividend Growth

Basel Medical Group does not have a long track record of dividend growth.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: N/A

Search Interest

1 people have searched for BMGL on MarketBeat in the last 30 days.

Company Ownership

• Score: N/A
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Basel Medical Group insiders have not sold or bought any company stock.

Percentage Held by Institutions

Basel Medical Group has minimal institutional ownership at this time.

BMGL Stock Analysis - Frequently Asked Questions

How have BMGL shares performed this year?

Basel Medical Group's stock was trading at $0.49 at the beginning of the year. Since then, BMGL stock has increased by 23.9% and is now trading at $0.6070.

When did Basel Medical Group IPO?

Basel Medical Group (BMGL) raised $10 million in an initial public offering on Tuesday, February 25th 2025. The company issued 2,205,000 shares at $4.00-$5.00 per share.

How do I buy shares of Basel Medical Group?

Shares of BMGL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 5/05/2026
• Fiscal Year End: 6/30/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Medical Services
• Sub-Industry: Healthcare
• Current Symbol: NASDAQ:BMGL
• CIK: 2004489
• Web: N/A
• Phone: (656) 291-9188
• Fax: N/A
• Employees: 36
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $8.90 million
• Price / Sales: 1.28
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.20 per share
• Price / Book: 3.04

Miscellaneous

• Outstanding Shares: 18,790,000
• Free Float: N/A
• Market Cap: $11.41 million
• Optionable: N/A
• Beta: 0.07